Clinical Trial Update: FLOT vs. FLOT/Ramucirumab for Perioperative Therapy of Gastric or GEJ Cancer (RAMSES) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial updating perioperative therapy for gastric or gastroesophageal junction cancer comparing FLOT versus FLOT with ramucirumab. Completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Junction Cancer
• Stomach Cancer

Drugs mentioned

• FLOT
• Ramucirumab (ramucirumab)

Snippet

Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Conditions: Stomach Cancer, Gastroesophageal Junction Cancer | Phase 2, Phase 3 | Status: COMPLETED